The in vitro results showed that the LTX/siR‐NPs could effectively inhibit TGF‐β1 expression and convert the nonimmunologically silent tumor cell death into an immunogenic way accompanied by the release of tumor‐associated antigens and danger signals for the DC activation. The gene discussed is TGFB1; the disease is neoplasm.